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Abstract
Background: The re-emergence of dengue virus 4 (DENV-4) has become a public health concern in South
America, Southeast Asia and South Asia. However, it has not been known to have caused a local outbreak in China
for the past 20 years. The purpose of this study was to elucidate the epidemiology of one local community
outbreak caused by DENV-4 in Guangzhou city, China, in 2010; and to determine the molecular characteristics of
the genotype II virus involved.
Case presentations: During September and October of 2010, one imported case, a Guangzhou resident who
travelled back from Thailand, resulted in 18 secondary autochthonous cases in Guangzhou City, with an incidence
rate of 5.53 per 10,000 residents. In indigenous cases, 14 serum samples tested positive for IgM against DENV and
7 for IgG from a total of 15 submitted serum samples, accompanied by 5 DENV-4 isolates. With identical envelope
gene nucleotide sequences, the two isolates (D10168-GZ from the imported index case and Guangzhou 10660
from the first isolate in the autochthonous cases) were grouped into DENV-4 genotype II after comparison to 32
previous DENV-4 isolates from GenBank that originated from different areas.
Conclusions: Based on epidemiological and phylogenetic analyses, the outbreak, which was absent for 20 years
after the DENV-4 genotype I outbreak in 1990, was confirmed as DENV-4 genotype II and initially traced to the
imported index case, a Guangzhou resident who travelled back from Thailand.
Background
Dengue is the most globally prevalent arthropod-borne
viral disease in humans [1]. Approximately 2.5 billion peo-
ple live in regions at risk and 50-100 million infections
occur annually, resulting in half a million individuals
suffering from dengue hemorrhagic fever (DHF) and more
than 25,000 deaths [2]. The total yearly cost of treatment
can reach US $2 billion, based on figures from five coun-
tries in the Americas (Brazil, El Salvador, Guatemala,
Panama, and Venezuela) and three countries in Asia
(Cambodia, Malaysia, and Thailand) [3]. The reported
number of dengue cases has increased dramatically in the
past five decades, mainly due to growing vector and
human population densities [4].
The agent of dengue virus (DENV) is a member of the
genus Flavivirus family Flaviviridae. It is a single-stranded,
positive-sense, RNA virus with a genome of about 11 kb,
which can be antigenically divided into four serotypes
(DENV-1, DENV-2, DENV-3, and DENV-4). All four ser-
otypes commonly cause a mild febrile illness which may
progress to DHF and dengue shock syndrome (DSS) [5].
In the past 10 years, DENV-4 has been re-emerging or
emerging in different countries and regions. After an
absence of 25 years, DENV-4 genotype II re-emerged in
Brazil in 2007 [6], followed by genotype I in northern
Brazil in 2010 [7]. The detection of DENV-4 was
reported for the first time in Easter Island in 2009, which
was serotyped as genotype II [8]. Although rarely
reported after the 1970s in India, DENV-4 re-emerged in
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detected in 2009 [9]. However, genotypes I, II, and III of
DENV-4 have been detected yearly in Thailand since
1963 [10]. DENV-4 genotype II has been isolated in the
Caribbean following introduction from Asia in 1981 [11].
In addition, DENV-4 had a higher rate of dispersion than
DENV-2 in the Americas during the study period [12]
and the evolutionary rate may increase following geogra-
phical expansion [13,14]. DENV-4 replaced DENV-3 as
the main epidemic strain in Peru in 2008 [15] and took
over DENV-1 as the primary epidemic strain in the Paci-
fic region from 2007 to 2009 [16]. Furthermore, severe
disease risk was positively correlated to DENV-4, espe-
cially for children after secondary infection following
antibody-dependent enhancement (ADE). In Thailand,
DENV-4 accounted for 10% of DHF cases in children,
and most DENV-4 DHF cases were associated with sec-
ondary dengue viral infection [10].
In recent years, much attention has focused on genetic
diversity in viral evolution. Viral genetic changes play a cri-
tical role in tracing the origin of infection, particularly
through sequencing and phylogenetic analyses of complete
envelope gene sequences from isolates [5], which may
result in more virulent or epidemic strains. The strains
from individual serotypes often fall into well-defined geno-
types, supported by high bootstrap values restricted to
particular geographic regions, which are reflective of the
extensive migration of both hosts and vectors [10]. To
date, four major genotypes of DENV-4 have been
described [17]: genotype I, representing strains from Thai-
land, the Philippines, Sri Lanka and Japan; genotype II,
representing strains from Indonesia, Malaysia, Tahiti, the
Caribbean and the Americas; genotype III, representing
Thai strains that are distinct from other Thai isolates; and
genotype IV, representing sylvatic strains from Malaysia.
Guangzhou, a megalopolis in China, is a representative
city that has experienced annual DENV transmission,
accounting for more than 50% of the DENV cases in main-
land China. In recent years, serotypes DENV-1, DENV-2,
DENV-3, and DENV-4 have been sequentially circulated in
Guangzhou. The DENV-3 serotype was identified in 2009
and was later replaced by DENV-4 in 2010. The first
DENV-4 outbreak in Guangzhou occurred in 1978, which
was transmitted from Foshan City, with a second DENV-4
outbreak occurring in 1990 [18,19]. After an absence of 20
years, the third DENV-4 outbreak took place in 2010.
In this paper, we investigated the DENV-4 outbreak in
the Jingtai Street community which covered 11.4 square
kilometres with a population of 32,567 in 2010. There was
a high density of Aedes albopictus which was identified as
the predominant vector for dengue in Guangzhou, with an
average Breteau index (BI) of 8.67 in the first three days
after the first autochthonous case was distinguished on
September 13, 2010. The survey enabled analysis of the
epidemiological distribution, laboratory testing and phylo-
genetic analyses of envelope gene sequences, using 2
sequences extracted from isolates and 32 sequences pub-
lished in GenBank.
Case presentations
Methods for survey and laboratory analysis
All patients were identified from passive surveillance
when seeking medical services or recognized by active
searches that were reported to the Notifiable Infectious
Disease Report System (NIDRS) within 24 hours after
diagnosis, and were followed by a face-to-face interview
conducted by the Center for Disease Control and Preven-
tion (CDC). Case definition, serological tests, and viral
isolation and identification from sera samples conformed
to the Diagnostic Criteria for Dengue Fever (WS216-
2008) enacted by the Chinese Ministry of Health [20]. In
addition, initial serum specimens of patients and 200
healthy persons for population serosurvey were obtained
with ethical approval from the Ethics Committee of the
Guangzhou Center for Disease Control and Prevention.
Written informed consent was obtained from all patients
upon seeking medical service.
A Dengue Duo IgM and IgG Capture ELISA Kit (Pan-
Bio, Windsor, Australia) was used to serologically diagnose
infections [21]. Viral RNA was extracted using the
QLAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany).
Three pairs of primers were designed with Primer Express
Software Version 3.0 (Applied Biosystems, Foster City,
CA, USA, see Additional file 1: Table S1 for details) to
amplify the entire DENV-4 envelope gene sequence. RNA
samples were used for one-step RT-PCR (TaKaRa, Shiga,
Japan). The PCR products were purified using QIA-quick
PCR Purification Kits (Qiagen) [22]. The envelope genes
were purified and completely sequenced using the BigDye
Terminator Cycle Sequencing Kit (Applied Biosystems)
applying previously described primers. Sequences assem-
blies were completed using the SeqMan II software
(DNASTAR, Inc., Madison, WI, USA).
T h ep h y l o g e n e t i ct r e ew a sc o n s t r u c t e db yt h en e i g h -
bour-joining method with a Kimura 2 parameter model
using MEGA 4.0 software (http://www.megasoftware.net/
mega4/mega.html). One thousand bootstrap repetitions
were used for confirmation of the statistical significance of
the phylogenetic analysis [22]. The DENV isolates (see
Additional file 2: Table S2 for details) used in this analysis
were published in GenBank. These isolates represented a
wide range of geographic localities, including earlier
sampled viruses and two sylvatic strains isolated from
monkeys in Malaysia.
Results
One imported case was confirmed. A total of 18 auto-
chthonous cases were identified that met the case
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Page 2 of 8definition, including 7 clinically diagnosed cases and 11
confirmed cases. Of these 18 cases, 16 patients were hos-
pitalized. Sixteen cases were identified from passive
reports and 2 cases among 18,324 residents from active
searches, which produced an incidence rate of 5.53 per
10,000 people. Moreover, 1 (0.50%) serum sample from a
healthy person tested positive for IgM in the serosurvey.
Imported case
The index imported patient, a 26-year-old female
Guangzhou resident from the Yuexiu District, had been
on vacation in Bangkok from August 25 to September 1,
2010. On the evening of August 31, prior to her flight
back to Guangzhou, she suffered from a sudden fever
with temperature of 38.5°C, followed by cephalgia,
malaise, arthralgia and exanthema on the forearms and
legs. The patient fully recovered 7 days after onset with
no hemorrhagic manifestation or other severe alterna-
tions. Before her tour to Thailand, she was healthy and
reported no febrile illness. After her return, on Septem-
ber 2, she visited a friend living on a fifth floor apartment
in Jingtai Street community. On the basis of the patient’s
symptoms and dengue prevalence in Bangkok, dengue
fever (DF) was confirmed and virus isolate D10168-GZ
(GenBank accession no. JN029829, submitted by the
Guangdong Center for Disease Control and Prevention,
China) was found in her serum. Interestingly, IgM and
IgG were negative on September 4, but were present on
September 8, 2010.
Secondary autochthonous cases
All 18 autochthonous cases were confined to the Jingtai
Street community in Guangzhou. The onset dates of
these cases ranged from September 6 to October 29,
2010, without a significant peak occurring on any single
day. Eleven cases (61.11%) were reported in September:
two on September 27 and one each on September 6, 7, 9,
11, 13, 14, 20, 21 and 30. Seven cases (38.89%) occurred
in October: one each on October 5, 8, 11, 16, 21, 23 and
29 (see Figure 1 for the dynamic of spread). The epidemic
lasted 53 days, with a median interval from time of onset
to report of six days (range: 2-12 days). The first auto-
chthonous case developed illness on September 6. She
lived on the third floor in the same building of the friend
visited by the imported index case on September 2. The
other autochthonous cases had no obvious gathering
activities but all lived in the Jingtai Street community.
The time distribution indicated a continuous dissemina-
tion, which was confined to a specific period.
The infected individuals consisted of eight males and
10 females with sex ratio of 1:1.25 and an average age of
41.68 years (range: 16-82 years). The ages included two
people aged 10-19 years, five aged 20-29 years, two aged
30-39 years, one aged 40-49 years, four aged 50-59
years, two aged 60-69 years and two that were more
than 70 years old.
The most commonly reported clinical manifestations are
listed in Table 1. All patients had fever (100%), 13 cases
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Figure 1 The dynamic of spread from the imported index case to 18 autochthonous cases in the DENV-4 genotype II outbreak from
Jingtai Street in Guangzhou, China, in 2010.
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Page 3 of 8(72.22%) reported skin petechiae, 10 cases (55.56%) experi-
enced rashes, eight (44.44%) suffered from myalgia and
three (16.67%) from arthralgia. The other reported symp-
toms included malaise (88.89%), cephalalgia (72.22%),
facial flushing (11.11%), conjunctival congestion (22.22%),
orbital pain (11.11%) and vomiting (5.56%). Clinical blood
tests indicated leukocytopenia in 16 cases (88.89%) and
thrombocytopenia in 12 cases (66.67%). The median dura-
tion of illness was 7 days (range: 3-14 days).
Indigenous cases are listed in Table 2. A total of 15
blood specimens were submitted with a median time
interval from onset to sampling of six days (range: 1-12
days). Fourteen serum samples tested positive for IgM
against DENV and seven for IgG against DENV. Five
DENV-4 strains were isolated with an isolate rate of
33.33% and an interval median of six days (range: 3-7
days) from sampling date to onset of symptoms.
Phylogenetic analysis
Envelope genes of five isolates from the autochthonous
cases and one isolate from the index imported case were
1485nt in length, with a homology of 99.9-100%. The
first isolate of the autochthonous cases was the isolate
Guangzhou 10660 (GenBank accession no. JN599977).
Guangzhou 10660 shared 100% homology with D10168-
GZ that was isolated in China in 2010 and imported
from Thailand, and also shared 98.9% homology with the
02-12-1HuNIID strain isolated in 2002 in Japan which
also was imported from Thailand (see Additional file 3:
Table S3 for homology details).
Phylogenetically, as demonstrated in Figure 2, Guangz-
hou 10660 and D10168-GZ are identical, and are located
in the same clade and grouped into DENV-4 genotype II.
These strains are closely related to 02-12-1HuNIID, and
are clustered within the same minor clade as 0712TW iso-
l a t e di nT a i w a ni n2 0 0 7a n di m p o r t e df r o mI n d o n e s i a ,
SW36i isolated in Indonesia in 2004, and 2641Y08 isolated
in Singapore in 2008. These strains are distantly related to
strain CN78-56 which was grouped into the genotype II
clade which was isolated in China in 1978, and remarkably
remote from the Guangzhou B5 strain which isolated in
China in 1990 and was grouped to the genotype I clade.
Conclusions
DENV-4 has not been identified in local outbreaks in
mainland China since the 1990 DENV-4 genotype I out-
break. Based on epidemiological and phylogenetic ana-
lyses, this current outbreak was confirmed as DENV-4
genotype II and initially traced to the imported index case,
a Guangzhou resident who travelled back from Thailand.
The DENV-4 genotype II spread rapidly (Figure 3), but
was not classified as a re-emergence of the DENV-4 out-
breaks from 1990 and 1978.
Dengue viruses are serologically classified into four
antigenically distinct serotypes (DENV-1, DENV-2,
Table 1 Symptoms observed in the 18 autochthonous
dengue cases from Jingtai Street in Guangzhou, 2010
Symptoms No. of cases
Fever 18 (100%)
Cephalalgia 13 (72.22%)
Arthralgia 3 (16.67%)
Myalgia 8 (44.44%)
Malaise 16 (88.89%)
Rash 10 (55.56%)
Facial flushing 2 (11.11%)
Skin petechiae 13 (72.22%)
Conjunctival congestion 4 (22.22%)
Orbital pain 2 (11.11%)
Vomiting 1 (5.56%)
Leukocytopenia 16 (88.89%)
Thrombocytopenia 12 (66.67%)
Table 2 The sex, age, antibody and viral isolation profiles
of the 18 indigenous cases from the DENV-4 outbreak
from Jingtai Street, Guangzhou, China, 2010
Num. Age(yr)/
Gender
Date of
Sampling
IgM IgG Viral
isolation
Case 1 30/F 9/13/2010 + + –
Case 2 31/F 9/13/2010 + - DENV-4
Case 3 29/F ND ND ND ND
Case 4 55/M 9/18/2010 + + DENV-4
Case 5 56/M 9/21/2010 + + –
Case 6 63/M 9/26/2010 + + –
Case 7 61/F 9/23/2010 + - DENV-4
Case 8 19/F 9/27/2010 + - DENV-4
Case 9 16/M 9/29/2010 + - DENV-4
Case
10
82/M 9/28/2010 - - –
Case
11
80/M 10/06/2010 + + –
Case
12
25/M ND ND ND ND
Case
13
25/F 10/11/2010 + - –
Case
14
22/F ND ND ND ND
Case
15
40/F 10/22/2010 + - –
Case
16
27/M 10/27/2010 + + –
Case
17
54/F 10/29/2010 + + –
Case
18
54/F 11/04/2010 + - –
Note: Num 3, Num 12 and Num 14 were clinically diagnosed cases and no
serum was sampled. ND: not done. –:no virus was isolated. IgM and IgG
results were from the first serums collected once patients sought medical
service.
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Figure 2 The phylogenetic analysis of the envelope gene sequences of DENV-4. The phylogenetic tree was constructed by the neighbour-
joining method with a Kimura 2 parameter model using MEGA 4.0 software. Bootstrap values were set for 1000 repetitions and were placed
over each main node of the tree. Name rule: country/strain name/isolated year/GenBank accession number. CL: Chile; CN: China; DM: Dominica;
ID: Indonesia; IN: India; KH: Cambodia; MM: Myanmar; MY: Malaysia; PE: Peru; PH: the Philippines; PR: Puerto Rico; SB: Solomon; SG: Singapore; TH:
Thailand; VE: Venezuela.
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Page 5 of 8DENV-3 and DENV-4). Different genotypes were
included in the same serotype according to envelope
gene sequences and confined to specific geographical
areas [23]. The envelope gene encodes an envelope pro-
tein, which induces membrane fusion, and confers pro-
tective immune responses by eliciting neutralizing,
antifusion and replication-enhancing antibodies [17]. The
envelope gene is the most commonly gene surveyed in
dengue molecular epidemiological studies [24]. Though
the cases were divergent, based on sampling time and
patient addresses, the DENV-4 isolates were determined
to be from the same origin.
Phylogenetics significantly contributed to the under-
standing of the relationship among the strains from differ-
ent areas and times, and to determining whether the
epidemic had re-emerged or was newly introduced. The
results indicated that the strain responsible for the out-
break in Guangzhou was introduced from Thailand, where
DENV-4 had circulated for a long time. This strain was
not a re-emergence of the DENV-4 outbreak of 1990.
Furthermore, results suggested that strain isolated from
Guangzhou in 2010 had evolved from the 2002 Thailand
strains.
In China, dengue is thought to be an imported epi-
demic disease [25]. In the past decades, severe dengue
epidemics have occurred in Southeast Asian countries,
including Thailand, Singapor e ,I n d o n e s i a ,a n dt h eP h i -
lippines, from which dengue was exported to adjacent
countries [26]. Moreover, this community outbreak also
was traced to Thailand, which is a major reservoir and
epicentre for dengue virus [10].
Guangzhou is the capital city of the Guangdong Pro-
vince in southern China, located at 112°57’E to 114°3’E
and 22°26’N to 23°56’N. Guangzhou has a current popu-
lation of more than 10 million and a humid subtropical
climate influenced by the Asian monsoon [27]. In addi-
tion, Guangzhou is one of the most important commer-
cial centers in China and Southeast Asia, and has a
large demographic exchange coupled with business,
tourism and labour service. Guangzhou is a hub for a
large number of tourists and is therefore connected to
large and busy roadways, railways, and airway systems
that allow easy access to the most populous part of
China. Furthermore, the local Aedes albopictus popula-
tions are large and susceptible to dengue virus. As a
result, the city is known as the most important point for
the introduction and dissemination of DENV in China.
Indeed, Guangzhou has accounted for more than 50% of
the dengue cases in mainland China since 1978. The
recent introduction of DENV-4 in this state should be
of a great concern because of its potential to spread to
the rest of China.
Figure 3 The source of the DENV-4 genotype II outbreak in Guangzhou City, 2010. The map in the box shows Southeast Asia. The right
map is an enlargement of Guangzhou City, where “▲” denotes the imported index case, a Guangzhou resident who travelled back from
Thailand, and “●” represents the 18 secondary autochthonous cases initiated by the imported index case.
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Page 6 of 8The imported index case, a Guangzhou resident who
travelled back from Thailand, spread the virus from the
Yuexiu District in Guangzhou. This case did not arouse
attention until the end of the outbreak. Therefore, early
detection of cases and a rapid public health response
might prevent the import of a dengue virus which may
then lead to an outbreak [28]. As Guangzhou is an ideal
location for a dengue epidemic, DENV-4 is a serious
threat. Thus, the Bureau of Health should prepare a
plan to adopt control measures to avoid or minimize
spread of this serotype, provide clinical management,
organize healthcare, and maintain an efficient surveil-
lance system to reduce the threat of dengue outbreaks
[29].
Consent
Written informed consent was obtained from the
patients for publication of this case report.
Additional material
Additional file 1: Table S1 The three pairs of primers used to
amplify and sequence the entire DENV-4 envelope gene.
Additional file 2: Table S2 The DENV-4 reference strains for
phylogenetic analysis.
Additional file 3: Table S3 The homologies among the isolates and
different strains from GenBank.
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